These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 8551394

  • 21. Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the gamma-globin gene in adult erythropoiesis.
    Xiang P, Han H, Barkess G, Olave I, Fang X, Yin W, Stamatoyannopoulos G, Li Q.
    Hum Mol Genet; 2005 Oct 15; 14(20):3047-56. PubMed ID: 16155112
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
    Bossé P, Bernex F, De Sepulveda P, Salaün P, Panthier JJ.
    Oncogene; 1997 Jun 05; 14(22):2661-70. PubMed ID: 9178764
    [Abstract] [Full Text] [Related]

  • 24. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice.
    Teitz T, Yen TS, Chang JC, Kan YW.
    DNA Cell Biol; 1994 Jul 05; 13(7):705-10. PubMed ID: 7772251
    [Abstract] [Full Text] [Related]

  • 25. Medullary thyroid carcinomas in transgenic mice expressing a Polyoma carboxyl-terminal truncated middle-T and wild type small-T antigens.
    Felici A, Giorgio M, Krauzewicz N, Della Rocca C, Santoro M, Rovere P, Manni I, Amati P, Pozzi L.
    Oncogene; 1999 Apr 08; 18(14):2387-95. PubMed ID: 10327060
    [Abstract] [Full Text] [Related]

  • 26. Unexpected and coordinated expression of Spi-1, Fli-1, and megakaryocytic genes in four Epo-dependent cell lines established from transgenic mice displaying erythroid-specific expression of a thermosensitive SV40 T antigen.
    Starck J, Mouchiroud G, Gonnet C, Mehlen A, Aubert D, Dorier A, Godet J, Morlé F.
    Exp Hematol; 1999 Apr 08; 27(4):630-41. PubMed ID: 10210321
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
    Gordon J, Del Valle L, Otte J, Khalili K.
    Oncogene; 2000 Oct 05; 19(42):4840-6. PubMed ID: 11039901
    [Abstract] [Full Text] [Related]

  • 29. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
    Lebel M, Webster M, Muller WJ, Royal A, Gauthier J, Mes-Masson AM.
    Cell Growth Differ; 1995 Dec 05; 6(12):1591-600. PubMed ID: 9019164
    [Abstract] [Full Text] [Related]

  • 30. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice.
    Reiner T, de Las Pozas A, Parrondo R, Perez-Stable C.
    Mol Cancer Res; 2007 Nov 05; 5(11):1171-9. PubMed ID: 17982114
    [Abstract] [Full Text] [Related]

  • 31. Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).
    Nabarra B, Pontoux C, Godard C, Osborne-Pellegrin M, Ezine S.
    Int J Exp Pathol; 2005 Dec 05; 86(6):397-413. PubMed ID: 16309545
    [Abstract] [Full Text] [Related]

  • 32. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
    Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M, Graessmann A.
    Oncogene; 2001 Apr 26; 20(18):2325-32. PubMed ID: 11402328
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
    Ebihara S, Endo S, Ito K, Ito Y, Akiyama K, Obinata M, Takai T.
    J Biochem; 2004 Sep 26; 136(3):321-8. PubMed ID: 15598888
    [Abstract] [Full Text] [Related]

  • 36. Inducible transformation of cells from transgenic mice expressing SV40 under lac operon control.
    Epstein-Baak R, Lin Y, Bradshaw V, Cohn M.
    Cell Growth Differ; 1992 Feb 26; 3(2):127-34. PubMed ID: 1504017
    [Abstract] [Full Text] [Related]

  • 37. Heritable lympho-epithelial thymoma resulting from a transgene insertional mutation.
    Nakajima H, Nakajima HO, Soonpaa MH, Jing S, Field LJ.
    Oncogene; 2000 Jan 06; 19(1):32-8. PubMed ID: 10644977
    [Abstract] [Full Text] [Related]

  • 38. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ, Robb L, Strasser A, Begley CG.
    Oncogene; 1997 Dec 11; 15(24):2975-83. PubMed ID: 9416841
    [Abstract] [Full Text] [Related]

  • 39. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene.
    Teitz T, Chang JC, Kitamura M, Yen TS, Kan YW.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2910-4. PubMed ID: 7681991
    [Abstract] [Full Text] [Related]

  • 40. A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family.
    Rassoulzadegan M, Courtneidge SA, Loubière R, el Baze P, Cuzin F.
    Oncogene; 1990 Oct 01; 5(10):1507-10. PubMed ID: 2123530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.